# **Laboratory Digital Governance Knowledge Base**
# **实验室数字治理知识库**

## Project Objective | 项目目标  

To systematically summarize my career experience in the laboratory industry, extracting transferable value from both successful practices and failures (anti-patterns). The goal is to build a practical knowledge base that goes beyond standard answers found in textbooks or regulations, serving as an evolving professional portfolio for personal career development.

系统性地总结我在实验室行业的职业经历，从正面实践和反面教训（反模式）中提炼可迁移的经验价值。目标是建立一个超越教科书或法规标准答案的实用知识库，作为适应社会与技术不断发展的个人名片。

##  Why This Project | 为什么做  

In the laboratory industry, most available information consists of regulatory standards (ISO 17025, GLP, etc.) or ideal-system blueprints. However, real-world experiences—especially the gaps between "what should be done" and "what is actually done," the compromises under commercial pressure, and the root causes of management tool failures—are rarely documented. This project aims to fill that gap by providing:
- Real-world industry insights from a practitioner's perspective.
- Abstracted models extracted from actual work scenarios, not copied from manuals.
- Actionable value for professionals facing similar challenges in regulated environments (pharmaceuticals, emerging industries, etc.).
This is not just a knowledge base; it is a living portfolio demonstrating my ability to observe, abstract, and solve problems.

实验室行业现有的资料大多是法规标准（ISO 17025、GLP等）或理想化的系统蓝图。然而，真实的行业经验——尤其是“应该怎么做”与“实际怎么做”之间的差距、商业压力下的妥协、管理工具失效的根本原因——却很少被记录。本项目旨在填补这一空白：
- 提供从业者视角的真实行业洞察。
- 从实际工作场景中抽象模型，而非抄写手册。
- 为医药、新兴行业等强监管环境中面临类似挑战的专业人士提供有实际价值的参考。
这不仅仅是一个知识库，更是一份展示我观察、抽象和解决问题能力的活名片。

##  Current Content | 当前内容  

The first version of the project architecture has been established:
```text
├── README.md                      # Project overview
├── business-map/                  # Laboratory business process modeling
├── lifecycle-model/               # Lifecycle control models (sample, data, report, etc.)
├── data-governance/               # ALCOA+, metadata, data integrity, etc.
├── audit-trail/                   # Audit trail management and pitfalls
├── risk-model/                    # Risk and exception classification
├── state-machine/                 # State transition definitions
├── architecture/                  # Digital control architecture
├── diagrams/                      # Visual models and flowcharts
├── prototypes/                    # Prototype designs for tools/systems
└── articles/                      # Industry insight articles
```
Published Articles (under articles/)
"Why Does Laboratory CAPA Always Fail? 7 Observations from a Practitioner"
Analysis of the real reasons behind CAPA ineffectiveness, ranked by probability, based on authentic industry experience.
"The Audit Trail Has Been Purchased for Years, But No One Has Ever Looked at It"
An exploration of why audit trails often become empty shells, from the perspectives of cognition, technology, management, and human factors.

已建立项目第一版架构：
```text
├── README.md                      # 项目概述
├── business-map/                  # 实验室业务流程建模
├── lifecycle-model/               # 生命周期控制模型（样品、数据、报告等）
├── data-governance/               # ALCOA+、元数据、数据完整性等
├── audit-trail/                   # 审计追踪管理与陷阱
├── risk-model/                    # 风险与异常分类
├── state-machine/                 # 状态转换定义
├── architecture/                  # 数字化控制架构
├── diagrams/                      # 可视化模型与流程图
├── prototypes/                    # 工具/系统原型设计
└── articles/                      # 行业洞察文章
```
已发布文章（位于 articles/ 目录）
《为什么实验室的CAPA永远在失效？一个从业者的7个观察》
基于真实行业经验，按概率排序分析CAPA失效的真实原因。
《审计追踪买了几年，从来没人看过》
从认知、采购、管理、人员四个层次探讨审计追踪沦为“空壳”的原因。

## Long-term Vision | 长期目标  

To evolve this knowledge base into a comprehensive experience database that provides:
- Technical solutions for digital governance in regulated industries (pharmaceuticals, medical devices, etc.).
- Management frameworks that address real-world constraints (commercial pressure, resource limits, organizational culture).
- Pattern libraries (both effective patterns and anti-patterns) that can be reused or adapted for different laboratory types and sizes.

Ultimately, this project aims to bridge the gap between regulatory ideal and operational reality—helping practitioners make better decisions, not just follow checklists.

将本知识库发展成为一个全面的经验数据库，提供：
- 满足医药、医疗器械等强监管行业需求的数字治理技术方案。
- 应对现实约束（商业压力、资源限制、组织文化）的管理框架。
- 可复用或适配于不同实验室类型与规模的模式库（包括有效模式和反模式）。

最终目标是弥合法规理想与运营现实之间的差距——帮助从业者做出更优决策，而不仅仅是遵循检查清单。

##Contribution & Feedback | 贡献与反馈

This project is primarily a personal knowledge portfolio, but insights and feedback from industry peers are always welcome. If you have similar experiences or suggestions, please feel free to open an issue or contact me directly.

本项目主要作为个人知识名片，但也欢迎行业同行的见解与反馈。如果您有类似经验或建议，欢迎提交Issue或直接联系我。

##License | 许可证

MIT License – free to use, share, and adapt with attribution.

采用 MIT 许可证——可自由使用、分享、改编，请保留署名。

## About the Author | 关于作者

Gilbert Chen – Laboratory quality management professional with 15 years of cross-industry experience (testing, certification, life sciences).
I specialize in bridging quality management systems (ISO 17025, CMA, ISO 15189) with technical enablers (Python/VBA/LIMS) to improve operational efficiency and data integrity. My hands-on experience spans:
System implementation & audit – Led multiple CNAS/ANAB accreditation and CMA certification projects.
Laboratory digitalization – Developed automation tools (report generation, data cleaning, format conversion) that reduced report processing time by over 80%; planned and drove LIMS implementation.
Data integrity – Designed technical solutions embedding regulatory requirements into daily workflows.
International project – Participated in the Angola "Huoyan Lab" (COVID-19 testing) from 0 to 1, establishing an ISO 15189 quality system and training 20+ local staff.
I am now systematically studying GMP and ICH Q10 pharmaceutical quality systems, aiming to apply my accumulated experience in quality management, audit response, and digital tool development to the pharmaceutical industry's compliance landscape.
Core capabilities: ISO 17025/15189/CMA, LIMS/OA, Python/VBA/R, GC-MS/HPLC, data integrity, audit (internal/external/client).
Education: Bachelor's in Pharmaceutical Engineering, Jilin University.

---

Gilbert Chen – 实验室质量管理从业者，拥有15年跨行业经验（检测、认证、生命科学）。
我擅长将质量管理体系（ISO 17025、CMA、ISO 15189）与技术工具（Python/VBA/LIMS）相结合，提升实验室运营效率与数据可靠性。我的实践经验涵盖：
体系搭建与审核 – 主导完成多项CNAS/ANAB认可、CMA资质认定项目。
实验室数字化 – 开发自动化工具（报告生成、数据清洗、格式转换），将报告处理时间缩短80%以上；策划推动LIMS落地。
数据完整性 – 设计将合规要求嵌入日常操作流程的技术方案。
国际项目经验 – 参与安哥拉“火眼实验室”从0到1建设，按ISO 15189搭建质量体系，完成20余名本地员工技术转移与培训。
目前正在系统学习GMP及ICH Q10制药质量体系，希望将积累的体系管理、审核应对、数字化工具开发能力应用于制药行业合规管理领域。
核心能力：ISO 17025/15189/CMA、LIMS/OA、Python/VBA/R、GC-MS/HPLC、数据完整性、审核（内部/外部/客户）
教育背景：吉林大学 制药工程 本科
